Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function

PHASE2CompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Delayed Graft Function
Interventions
DRUG

OPN-305

Intravenous infusion for 1 hour at start of transplant procedure

DRUG

Placebo

Intravenous infusion for 1 hour at start of transplant procedure

Trial Locations (50)

1090

Research Site, Brussels

3000

Research Site, Leuven

3015

Research Site, Rotterdam

4000

Research Site, Liège

6525

Research Site, Nijmegen

8091

Research Site, Zurich

9000

Research Site, Ghent

9700

Research Site, Groningen

10065

Research Site, New York

10117

Research Site, Berlin

10467

Research Site, The Bronx

13353

Research Site, Berlin

14021

Research Site, Prague

17105

Research Site, Harrisburg

20007

Research Site, Washington D.C.

23298

Research Site, Richmond

28041

Research Site, Madrid

29425

Research Site, Charleston

31409

Research Site, Toulouse

33076

Research Site, Bordeaux

33606

Research Site, Tampa

39008

Research Site, Santander

44892

Research Site, Bochum

48149

Research Site, Münster

51109

Research Site, Cologne

53127

Research Site, Bonn

60612

Research Site, Chicago

68135

Research Site, Mannheim

69120

Research Site, Heidelberg

70112

Research Site, New Orleans

70121

Research Site, New Orleans

72076

Research Site, Tübingen

75246

Research Site, Dallas

75743

Research Site, Paris

76104

Research Site, Fort Worth

90033

Research Site, Los Angeles

90154

Research Site, Erlangen

07039

Research Site, Livingston

A-4020

Research Site, Linz

NL-2300 RC

Research Site, Leiden

85-094

Research Site, Bydgoszcz

90-153

Research Site, Lodz

70-111

Research Site, Szczecin

02-006

Research Site, Warsaw

02507

Research Site, Warsaw

08003

Research Site, Barcelona

08036

Research Site, Barcelona

08907

Research Site, Barcelona

SE1 9RT

Research Site, London

NE7 7DN

Research Site, Newcastle upon Tyne

Sponsors
All Listed Sponsors
lead

Opsona Therapeutics Ltd.

INDUSTRY